A Phase 2/3, Multi-Center, Double-Blind, Placebo-Controlled, Randomized, Parallel-Group, Dose-Response Comparison of the Efficacy and Safety of a Topical Rapamycin Cream for the Treatment of Facial Angiofibromas (FA) Associated With Tuberous Sclerosis Complex (TSC) in Patients 6 Years of Age and Over
The study aims to compare the safety and efficacy of two different strengths of Rapamycin cream, topical and placebo over 26 weeks in the treatment of facial angiofibroma (FA) associated with Tuberous Sclerosis Complex (TSC).
100 项与 Dermatology Specialties Limited Partnership 相关的临床结果
0 项与 Dermatology Specialties Limited Partnership 相关的专利（医药）
100 项与 Dermatology Specialties Limited Partnership 相关的药物交易
100 项与 Dermatology Specialties Limited Partnership 相关的转化医学
